COVID-19 mortality in women and men in sub-Saharan Africa: a cross-sectional study.
COVID-19
epidemiology
Journal
BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
18
08
2021
accepted:
24
10
2021
entrez:
24
11
2021
pubmed:
25
11
2021
medline:
15
12
2021
Statut:
ppublish
Résumé
Since sex-based biological and gender factors influence COVID-19 mortality, we wanted to investigate the difference in mortality rates between women and men in sub-Saharan Africa (SSA). We included 69 580 cases of COVID-19, stratified by sex (men: n=43 071; women: n=26 509) and age (0-39 years: n=41 682; 40-59 years: n=20 757; 60+ years: n=7141), from 20 member nations of the WHO African region until 1 September 2020. We computed the SSA-specific and country-specific case fatality rates (CFRs) and sex-specific CFR differences across various age groups, using a Bayesian approach. A total of 1656 deaths (2.4% of total cases reported) were reported, with men accounting for 70.5% of total deaths. In SSA, women had a lower CFR than men (mean [Formula: see text] = -0.9%; 95% credible intervals (CIs) -1.1% to -0.6%). The mean CFR estimates increased with age, with the sex-specific CFR differences being significant among those aged 40 years or more (40-59 age group: mean [Formula: see text] = -0.7%; 95% CI -1.1% to -0.2%; 60+ years age group: mean [Formula: see text] = -3.9%; 95% CI -5.3% to -2.4%). At the country level, 7 of the 20 SSA countries reported significantly lower CFRs among women than men overall. Moreover, corresponding to the age-specific datasets, significantly lower CFRs in women than men were observed in the 60+ years age group in seven countries and 40-59 years age group in one country. Sex and age are important predictors of COVID-19 mortality globally. Countries should prioritise the collection and use of sex-disaggregated data so as to design public health interventions and ensure that policies promote a gender-sensitive public health response.
Identifiants
pubmed: 34815243
pii: bmjgh-2021-007225
doi: 10.1136/bmjgh-2021-007225
pmc: PMC8611236
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Clin Infect Dis. 2020 Jul 28;71(15):863-865
pubmed: 32232322
Lancet Glob Health. 2021 Jan;9(1):e14-e15
pubmed: 33160453
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33028702
BMC Public Health. 2016 Nov 3;16(1):1136
pubmed: 27809824
J Glob Health. 2020 Dec;10(2):020513
pubmed: 33312506
Clin Infect Dis. 2020 Dec 3;71(9):2488-2494
pubmed: 32473009
BMJ Glob Health. 2022 Apr;7(4):
pubmed: 35418411
Proc R Soc Lond A Math Phys Sci. 1946;186(1007):453-61
pubmed: 20998741
Am J Transl Res. 2020 Oct 15;12(10):6537-6548
pubmed: 33194050
Lancet. 2020 Mar 14;395(10227):846-848
pubmed: 32151325
AIDS Behav. 2020 Nov;24(11):2995-2998
pubmed: 32451937
Wien Klin Wochenschr. 2021 Apr;133(7-8):393-398
pubmed: 33351155
Front Med (Lausanne). 2020 Jun 23;7:348
pubmed: 32671082
PLoS One. 2021 Jun 14;16(6):e0253193
pubmed: 34125851
Lancet. 2020 Aug 22;396(10250):565-582
pubmed: 32828189
PLoS Negl Trop Dis. 2015 Jul 16;9(7):e0003846
pubmed: 26181387
SN Compr Clin Med. 2020;2(8):1069-1076
pubmed: 32838147
MD Comput. 1991 May-Jun;8(3):157-71
pubmed: 1857193
Lancet. 2012 Aug 11;380(9841):611-9
pubmed: 22883510
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
Lancet Neurol. 2007 Mar;6(3):269-78
pubmed: 17303533
Nat Commun. 2020 Dec 9;11(1):6317
pubmed: 33298944
Lancet. 2020 Aug 22;396(10250):532-533
pubmed: 32798449
mBio. 2021 Feb 9;12(1):
pubmed: 33563817
Glob Health Action. 2014 May 05;7:23742
pubmed: 24804863
EClinicalMedicine. 2021 Sep;39:101054
pubmed: 34368662
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
Biol Sex Differ. 2020 May 25;11(1):29
pubmed: 32450906
J Med Virol. 2021 Mar;93(3):1449-1458
pubmed: 32790106
Arch Bronconeumol. 2021 Jan;57:21-34
pubmed: 34629638
BMJ Open. 2020 Oct 6;10(10):e040129
pubmed: 33028563
BMC Public Health. 2020 Nov 19;20(1):1742
pubmed: 33213391
Front Immunol. 2020 Aug 28;11:2147
pubmed: 32983176
BMJ. 2021 Feb 17;372:n334
pubmed: 33597166
Lancet. 2020 Sep 5;396(10252):649
pubmed: 32891195
Front Sociol. 2021 Jun 15;6:650729
pubmed: 34212026
Front Public Health. 2020 Apr 29;8:152
pubmed: 32411652
Lancet. 2019 Jun 22;393(10190):2535-2549
pubmed: 31155270
Front Immunol. 2021 Jun 17;12:693269
pubmed: 34220854
Lancet Glob Health. 2019 Oct;7(10):e1295-e1296
pubmed: 31537347